Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications evaluation measurement strategy parkinsons disease assessing patient health related
… Labeling The last decade has seen an increased focus on patient-centered drug development. Product labeling based on … The Patient-Centered Outcomes Assessment team at RTI Health Solutions has analyzed FDA PRO labeling over the past … our experts in patient-centered outcomes and market access strategy have a conversation about their findings. They will …
… local markets. Key sections in a GVD include: Value story Disease burden Unmet needs Value of the product (clinical, humanistic, economic ) Market access strategy Objection handling Slide Sets To help you … help answer. Key Factors Key Questions About Your Product Patient Perspective Can I afford it? Is it easy for me to …
… events related to diabetes Peripheral vascular disease Diabetic foot ulcers Obesity Types of Projects We … Economic burden of illness studies Literature reviews Measurement of patient preferences for treatment options … (PRO) studies Stated-choice studies Survey development, evaluation and implementation Therapy adherence studies Value …
… more large-molecule drugs or biologicals instead. On the disease-area level, companies might be thinking of … individual drugs in development , we will see changes in strategy, particularly for phase 2b or 3, where pivotal … understand disease burdens, unmet medical needs, and patient preferences. We support clinical trial design by …
… Joan Forns, MPH, PhD Research Epidemiologist RTI Health Solutions Transcript: Psychosis is a common … prevalence is higher in Parkinson’s and Alzheimer’s disease compared to other types of dementia. Antipsychotics … therefore, issued a black box warning for this indication. Assessing the risk of mortality associated with …
… and consumers’ knowledge, attitudes, and perceptions of a disease for which there is currently not a vaccine available. … milestones across the studies, while meeting deadlines for publications. OUR APPROACH We assembled a core team of researchers with backgrounds in public health, infectious diseases, pharmacy, statistics, and …
… program For a successful product development strategy, you need to prove value to a wide range of … program—from market access, outcomes research, patient preference, and economic evaluation, to reimbursement and safety activities. We start …
… by: Emma Hawe, MSc Head, Data Analytics and Design Strategy RTI Health Solutions Joint Clinical Assessments … (background information on patient population, burden of disease, comparators and their use); technical (description … HTA domains, which mainly involve cost, economic evaluation, and ethical aspects remain with the national HTA …
… coverage, benefits, and risks in Europe to support public health and decision making. Additionally, we collaborate with … Research (CEIFE) The Spanish Working Group on Chron’s Disease and Ulcerative Colitis (GETECCU), holds ENEIDA patient register SWEDEN Karolinska Institute UNITED KINGDOM …
… Real World Data Research Challenge: Assigning Treatment Strategy Share on: August 22, 2019 A Challenge of Real World … Martinez , MD, PhD Senior Research Epidemiologist RTI Health Solutions Transcript: When using observational data, … intervals. Read the full research at this link . Related Services Pharmacoepidemiology and Risk Management …